Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe) Analysis, Outlook, & Forecast by 2022

Albany, US, 2018-Mar-14 — /EPR Network/ —An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022) which provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering Asia Pacific, the Americas, Europe and Middle East Africa region along with the global Lysosomal Storage Disease market.

Get a free sample report@

Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.

The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy. However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.

The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the global market. The report profiles the key players of the market including Pfizer Inc., Sanofi S.A., Shire Plc and Protalix BioTherapeutics, Inc.

Browse full report with detailed table of content @

Table of Content:

  1. Market Overview
    1.1 Lysosomal Storage Disease (LSD)
    1.2 Classification of LSD
    1.3 Symptoms
    1.4 Diagnosis
    1.5 Treatment
    1.6 Upcoming Treatment
  2. 2. Global LSD Market Analysis
    2.1 Global LSD Market Forecast by Value
    2.2 Global LSD Market Value by Category
    2.3 Global Fabry Disease Market Forecast by Value
    2.4 Global Fabry Disease Market Value by Drugs
    2.4.1 Global Fabrazyme Sales Value
    2.4.2 Global Replagal Sales Value
    2.4.3 Global Galafold Sales Value
    2.5 Global Gaucher Disease Market Forecast by Value
    2.6 Global Gaucher Disease Market Value by Drugs
    2.6.1 Global Cerezyme Sales Value
    2.6.2 Global Vipriv Sales Value
    2.6.3 Global Cerdelga Sales Value
    2.7 Global Pompe Disease Market Forecast by Value
    2.8 Global Pompe Disease Market Value by Drugs
    2.8.1 Global Myozyme Sales Value

…………continue (List of Tables and Figures)

Enquire about this report @

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us:
90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)



Read Industry News at-

Matched content

Editor’s pick